Evaluation of potentially inappropriate medications in elderly polypharmacy patients with diabetes mellitus according to Beers criteria combined with STOPP criteria

CHANG Yanan; WANG Na; ZHANG Yan

doi:10.6039/j.issn.1001-0408.2024.24.19

您当前的位置：

首页 >

文章列表页 >

Evaluation of potentially inappropriate medications in elderly polypharmacy patients with diabetes mellitus according to Beers criteria combined with STOPP criteria

更新时间：2024-12-26

- Evaluation of potentially inappropriate medications in elderly polypharmacy patients with diabetes mellitus according to Beers criteria combined with STOPP criteria
- ZHONGGUO YAOFANG Vol. 35, Issue 24, Pages: 3076-3080(2024)
- 作者机构：
  
  1.河北医科大学药学院，石家庄　050017
  2.秦皇岛市第一医院药学部，河北秦皇岛　066000
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.24.19
  CLC： R969.3
- Published：30 December 2024，
  
  Received：29 April 2024，
  
  Revised：03 December 2024，
- 稿件说明：
移动端阅览
常亚男,王娜,张岩.Beers联合STOPP标准评估老年糖尿病多重用药患者潜在不恰当用药 ^Δ[J].中国药房,2024,35(24):3076-3080.

CHANG Yanan,WANG Na,ZHANG Yan.Evaluation of potentially inappropriate medications in elderly polypharmacy patients with diabetes mellitus according to Beers criteria combined with STOPP criteria[J].ZHONGGUO YAOFANG,2024,35(24):3076-3080.
常亚男,王娜,张岩.Beers联合STOPP标准评估老年糖尿病多重用药患者潜在不恰当用药 ^Δ[J].中国药房,2024,35(24):3076-3080. DOI： 10.6039/j.issn.1001-0408.2024.24.19.

CHANG Yanan,WANG Na,ZHANG Yan.Evaluation of potentially inappropriate medications in elderly polypharmacy patients with diabetes mellitus according to Beers criteria combined with STOPP criteria[J].ZHONGGUO YAOFANG,2024,35(24):3076-3080. DOI： 10.6039/j.issn.1001-0408.2024.24.19.

摘要

目的

为老年糖尿病患者安全用药提供参考。

方法

随机选取河北省两家三级综合医院2022年每个月1天中出院年龄≥65岁且长期用药≥5种的老年糖尿病患者的临床资料，分别采用2023版Beers标准和2023版老年人潜在不适当处方筛查工具（STOPP标准）对患者的潜在不适当用药（PIM）进行分析，采用多因素Logistic回归分析PIM的影响因素。

结果

共纳入227例患者。参照Beers标准，有157例患者（69.16%）检出PIM，检出PIM例次最多的药物有质子泵抑制剂（PPIs）、钠-葡萄糖耦联转运体2抑制剂和利伐沙班；参照STOPP标准，有142例患者（62.56%）检出PIM，主要涉及的药品为非甾体抗炎药和PPIs。多因素Logistic回归分析结果显示，年龄≥80岁、同时合并其他慢病数≥4种、长期用药数≥10种、住院天数≥8 d、用药方案复杂性指数评分≥20分，以及合并高血压、冠心病、脑血管病均是发生PIM的影响因素。

结论

老年糖尿病患者PIM检出率较高，Beers标准对PIM的识别比STOPP标准更敏感；临床应重点关注高龄、同时合并多种慢病、长期用药数多、住院时间长、用药方案复杂的患者，加强对其合理用药管理。

Abstract

OBJECTIVE

To provide a reference for the safe use of drugs in elderly patients with diabetes mellitus.

METHODS

Clinical data of elderly diabetic patients aged ≥65 years old and with ≥5 types of long-term medication who were admitted to two tertiary general hospitals in Hebei Province one day a month in 2022 were randomly selected. 2023 Beers criteria and 2023 STOPP criteria were used to analyze the potentially inappropriate medication （PIM） of the patients； multivariate Logistic regression was used to analyze the influencing factors of PIM.

RESULTS

A total of 227 patients were included. According to the Beers criteria， 157 patients （69.16%） had PIM， and the drugs with the most frequent cases of PIM were proton pump inhibitors （PPIs）， sodium-glucose linked transporter-2 inhibitors and rivaroxaban. According to the STOPP criteria， 142 patients （62.56%） had PIM， and the main drugs involved were non-steroidal anti-inflammatory drugs and PPIs. The results of multivariate Logistic regression analysis showed that patients with age ≥80 years old， with ≥4 other types of chronic diseases， ≥10 types of long-term medication， ≥8 days of hospitalization， medication regimen complexity index scoring ≥20 points of medication regimen， and complication with hypertension， coronary heart disease， and cerebrovascular diseases were influential factors for PIM.

CONCLUSIONS

The detection rate of PIM is high in elderly patients with diabetes mellitus， and the Beers criteria are more sensitive to PIM than the STOPP criteria. Clinically， we should focus on patients who are elderly， have multiple chronic diseases at the same time， have a large number of long-term medications， have a long hospital stay， have complex medication regimens， and strengthen their rational drug management.

关键词

老年糖尿病多重用药潜在不适当用药影响因素合理用药

Keywords

polypharmacypotentially inappropriate medicationinfluential factorsrational use of drugs

references

SUN H，SAEEDI P，KARURANGA S，et al. IDF diabetes atlas：global，regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract，2022，183：109119.

GBD Diabetes Collaborators. Global，regional，and national burden of diabetes from 1990 to 2021，with projections of prevalence to 2050：a systematic analysis for the global burden of disease study 2021[J]. Lancet，2023，402（10397）：203-234.

WANG L M，PENG W，ZHAO Z P，et al. Prevalence and treatment of diabetes in China，2013-2018[J]. JAMA，2021，326（24）：2498-2506.

贠菊平，裴雨晴，谷清. 老年2型糖尿病患者用药特点分析[J]. 中国临床药理学杂志，2021，37（3）：315-317.

YUN J P，PEI Y Q，GU Q. Analysis of medication characteristics of elderly patients with type 2 diabetes mellitus[J]. Chin J Clin Pharmacol，2021，37（3）：315-317.

陈晓敏，张丽娜，李友佳. 高龄老年2型糖尿病患者多重用药特点分析[J]. 中国全科医学，2023，26（10）：1271-1277.

CHEN X M，ZHANG L N，LI Y J. Characteristic of polypharmacy in older adults with type 2 diabetes[J]. Chin Gen Pract，2023，26（10）：1271-1277.

American Geriatrics Society. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inap-propriate medication use in older adults[J]. J Am Geriatr Soc，2023，71（7）：2052-2081.

O’MAHONY D，CHERUBINI A，GUITERAS A R，et al. STOPP/START criteria for potentially inappropriate prescribing in older people：version 3[J]. Eur Geriatr Med，2023，14（4）：625-632.

张金秀，徐晖，姜洪满. 某院500例住院患者他汀类药物应用情况分析[J]. 临床合理用药杂志，2022，15（36）：168-171.

ZHANG J X，XU H，JIANG H M. Analysis on the application of statins in 500 inpatients in a hospital[J]. Chin J Clin Ration Drug Use，2022，15（36）：168-171.

沈雪婷，寿涓，周敬，等. 处方复杂度量表的汉化改良与在老年糖尿病患者中的信效度检验[J]. 中华全科医师杂志，2022，21（9）：840-846.

SHEN X T，SHOU J，ZHOU J，et al. Development of the modified medication regimen complexity index of Chinese version（mMRCI-C） and its validation in elderly diabetic patients[J]. Chin J Gen Pract，2022，21（9）：840-846.

WAKAI E，IKEMURA K，KATO C，et al. Effect of number of medications and complexity of regimens on medication adherence and blood pressure management in hospitalized patients with hypertension[J]. PLoS One，2021，16（6）：e0252944.

杨婉莹，周湘明，缪园园，等. 肾脏不适当用药对老年糖尿病患者衰弱的影响[J]. 中国药房，2024，35（2）：214-218.

YANG W Y，ZHOU X M，MIAO Y Y，et al. The influence of renally inappropriate medication on the frailty of elderly patients with diabetes[J]. China Pharm，2024，35（2）：214-218.

LU L L，YAO K Q，CHEN J Q，et al. Prevalence of potentially inappropriate medications and association with comorbidities in older adults with diabetes in an outpatient visitation setting[J]. Front Public Health，2022，10：995948.

WANG Y P，ZHU J，SHAN L C，et al. Potentially inappropriate medication among older patients with diabetic kidney disease[J]. Front Pharmacol，2023，14：1098465.

BRUNETTI E，AURUCCI M L，BOIETTI E，et al. Clinical implications of potentially inappropriate prescribing according to STOPP/START version 2 criteria in older polymorbid patients discharged from geriatric and internal medicine wards：a prospective observational multicenter study[J]. J Am Med Dir Assoc，2019，20（11）：1476.e1-1476.e10.

MA Z，TONG Y L，ZHANG C X，et al. Potentially inappropriate medications and potentially prescribing omissions in Chinese older patients：comparison of two versions of STOPP/START[J]. J Clin Pharm Ther，2020，45（6）：1405-1413.

LU L L，WANG S，CHEN J Q，et al. Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes[J]. Front Pharmacol，2023，14：1284287.

质子泵抑制剂预防性应用专家共识写作组. 质子泵抑制剂预防性应用专家共识：2018 [J]. 中国医师杂志，2018，20（12）：1775-1781.

Writing Group of Expert Consensus on the Preventive Application of Proton Pump Inhibitors. Expert consensus on the preventive application of proton pump inhibitors：2018 [J]. J Chin Physician，2018，20（12）：1775-1781.

张倩，李沭，李朋梅. 美国老年医学会老年人潜在不适当用药Beers标准2023版解读[J]. 中国全科医学，2023，26（35）：4372-4381.

ZHANG Q，LI S，LI P M. Interpretation of the 2023 AGS Beers criteria：potentially inappropriate medication use in older adults[J]. Chin Gen Pract，2023，26（35）：4372-4381.

CHEN X，WANG L L，LI H J，et al. Comparative diffe-rences in the risk of major gastrointestinal bleeding among different direct oral anticoagulants：an updated traditional and Bayesian network meta-analysis[J]. Front Pharmacol，2022，13：1049283.

BARÉ M，LLEAL M，ORTONOBES S，et al. Factors associated to potentially inappropriate prescribing in older patients according to STOPP/START criteria：MoPIM multicentre cohort study[J]. BMC Geriatr，2022，22（1）：44.

HOLT A，STRANGE J E，NOUHRAVESH N，et al. Heart failure following anti-inflammatory medications in patients with type 2 diabetes mellitus[J]. J Am Coll Cardiol，2023，81（15）：1459-1470.

何梅，邵鑫，赵曜，等. Beers标准、STOPP/START标准及中国PIM初级判断标准评价某院心血管内科医嘱的对比研究[J]. 中国医院药学杂志，2018，38（7）：781-784，791.

HE M，SHAO X，ZHAO Y，et al. Comparison of the Beers criteria，STOPP/START criteria and Chinese potentially inappropriate medication primary judgment criteria in evaluating prescription orders in cardiovascular department[J]. Chin J Hosp Pharm，2018，38（7）：781-784，791.

ALBAYRAK A，DEMIRBAŞ H. Evaluation of potentially inappropriate medications use and medication complexity in elderly patients applying to community pharmacy in Turkey[J]. BMC Geriatr，2023，23（1）：655.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Practice and effect evaluation of refined setting of evidence-based reference prescription pre-audit rules in anesthesiology department

Mining and analysis of adverse drug event signals related to macitentan

Investigation and analysis of the review and comment on inpatient medical orders in Beijing municipal hospitals

Application and evaluation of management mode for the use of antimicrobial drugs in county-level medical communities led by anti-infective clinical pharmacists

Expert consensus on comprehensive clinical evaluation of antidepressant drugs

Related Author

XING Xiaomin

LI Xiangpeng

WANG Xinyi

WEI Lina

LI Wenjing

LI Jing

WU Zhenhu

CHEN Xinyao

Related Institution

Dept. of Pharmacy， the Affiliated Hospital of Qingdao University

School of Public Health， Sun Yat-sen University

The Second Clinical Medical College， Guangzhou University of Chinese Medicine

Dept. of Respiratory and Critical Care Medicine， Guangdong Provincial Hospital of Chinese Medicine

Material and Equipment Center， Beijing Chaoyang Hospital， Capital Medical University

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰